Work

The Effects of Antimicrobials and Microbial Consortia on Human Gut Microbiota and Antibiotic Resistance Genes

Year: 2022
Type: dissertation
Study design: Observational Study
Abstract: The human gut microbiome is a significant contributor to health and disease. Numerous host and environmental factors are associated with perturbation of gut microbiome composition. Antibiotics significantly alter the composition and function of the gut microbiome, but dose, class and duration-specific antimicrobial effects are not well studied. As it becomes increasingly clear that perturbation of the microbiome is associated with adverse health outcomes, we must understand what factors influence microbiome composition, how to measure relevant aspects of microbiome composition and function, and identify therapeutic targets to remediate or protect the microbiome from iatrogenic perturbation. The first aim of this thesis was to understand the differential effects of antibiotic type and duration on the composition of the microbiota to inform antibiotic therapy that limits its disruption. In a retrospective cohort of 72 term and preterm infants in the neonatal intensive care unit we compared the composition of the microbiota within one week post antimicrobial exposure between infants who received ampicillin plus tobramycin, ampicillin plus cefotaxime, or ampicillin plus tobramycin plus metronidazole. No differences in the composition of the microbiota were observed between treatment groups, but we observed that each additional day of antibiotics was associated with decreased health-associated anaerobes. Our next aim was to validate sequencing and bioinformatic methods to enable accurate detection of antimicrobial resistance genes in a metagenome to inform sequencing requirements for clinical studies. We found that 30 million sequencing reads would be required to detect antimicrobial resistance genes in organisms comprising 1% of a microbial community. Finally, in a post-hoc analysis of a clinical trial of a microbial consortium for treatment of recurrent Clostridioides difficile infection, we found that treatment was associated with multiple-log decreases in Proteobacteria abundance and antimicrobial resistance genes, and sustained increases in health-associated anaerobes. Together these data demonstrate the daily harms of antibiotics on the composition of the gut microbiota where microbial consortia may be an effective strategy for remediating the gut microbiome post-antimicrobial exposure.
Language: English
Open Access status: green
OpenAlex ID: W7133018980
Cites: 275
Cited by:
Related to: 10